Overall Concordance Rates of the Change of the Different Single Items and Overall Response Using Simple Kappa Coefficient: Median (Lower-Upper Quartile) Between Baseline and Follow-Up MRI
MRI findings . | All raters (N = 35) . | Neuroradiologists and neurologists (N = 26) . | Neurologists only (N = 17) . | Neuroradiologists only (N = 9) . | P-value between neurologists and neuroradiologists . |
---|---|---|---|---|---|
Number of Kappa analysis | N = 595 | N = 325 | N = 153 | N = 136 | |
LM-related items | |||||
Brain nodules | 0.32 (0.14–0.5) | 0.29 (0.12–0.48) | 0.29 (0.14–0.48) | 0.31 (–0.07 to 0.57) | .3702 |
Brain linear disease | 0.18 (–0.08 to 0.37) | 0.18 (–0.07 to 0.35) | 0.15 (–0.07 to 0.35) | 0.22 (–0.07 to 0.35) | .3050 |
Hydrocephalus | 0.64 (0.44–0.77) | 0.64 (0.45–0.77) | 0.64 (0.45–0.77) | 0.69 (0.54–0.83) | .0259 |
Spinal nodules | 0.58 (0.38–0.74) | 0.58 (0.34–0.73) | 0.61 (0.36–0.77) | 0.46 (0.31–0.65) | .0511 |
Spinal linear disease | 0.44 (0.22–0.63) | 0.52 (0.31–0.65) | 0.45 (0.29–0.6) | 0.66 (0.45–0.84) | .0004 |
Overall response | 0.44 (0.29–0.58) | 0.46 (0.31–0.6) | 0.46 (0.34–0.61) | 0.4 (0.29–0.6) | .2174 |
Non-LM-related items | |||||
Brain parenchymal metastases | 0 (–0.09 to 0.49) | 0 (–0.09 to 0.45) | 0.21 (–0.09 to 0.48) | –0.08 (–0.08 to 0.38) | .1093 |
MRI findings . | All raters (N = 35) . | Neuroradiologists and neurologists (N = 26) . | Neurologists only (N = 17) . | Neuroradiologists only (N = 9) . | P-value between neurologists and neuroradiologists . |
---|---|---|---|---|---|
Number of Kappa analysis | N = 595 | N = 325 | N = 153 | N = 136 | |
LM-related items | |||||
Brain nodules | 0.32 (0.14–0.5) | 0.29 (0.12–0.48) | 0.29 (0.14–0.48) | 0.31 (–0.07 to 0.57) | .3702 |
Brain linear disease | 0.18 (–0.08 to 0.37) | 0.18 (–0.07 to 0.35) | 0.15 (–0.07 to 0.35) | 0.22 (–0.07 to 0.35) | .3050 |
Hydrocephalus | 0.64 (0.44–0.77) | 0.64 (0.45–0.77) | 0.64 (0.45–0.77) | 0.69 (0.54–0.83) | .0259 |
Spinal nodules | 0.58 (0.38–0.74) | 0.58 (0.34–0.73) | 0.61 (0.36–0.77) | 0.46 (0.31–0.65) | .0511 |
Spinal linear disease | 0.44 (0.22–0.63) | 0.52 (0.31–0.65) | 0.45 (0.29–0.6) | 0.66 (0.45–0.84) | .0004 |
Overall response | 0.44 (0.29–0.58) | 0.46 (0.31–0.6) | 0.46 (0.34–0.61) | 0.4 (0.29–0.6) | .2174 |
Non-LM-related items | |||||
Brain parenchymal metastases | 0 (–0.09 to 0.49) | 0 (–0.09 to 0.45) | 0.21 (–0.09 to 0.48) | –0.08 (–0.08 to 0.38) | .1093 |
LM, leptomeningeal metastasis; N, number
Overall Concordance Rates of the Change of the Different Single Items and Overall Response Using Simple Kappa Coefficient: Median (Lower-Upper Quartile) Between Baseline and Follow-Up MRI
MRI findings . | All raters (N = 35) . | Neuroradiologists and neurologists (N = 26) . | Neurologists only (N = 17) . | Neuroradiologists only (N = 9) . | P-value between neurologists and neuroradiologists . |
---|---|---|---|---|---|
Number of Kappa analysis | N = 595 | N = 325 | N = 153 | N = 136 | |
LM-related items | |||||
Brain nodules | 0.32 (0.14–0.5) | 0.29 (0.12–0.48) | 0.29 (0.14–0.48) | 0.31 (–0.07 to 0.57) | .3702 |
Brain linear disease | 0.18 (–0.08 to 0.37) | 0.18 (–0.07 to 0.35) | 0.15 (–0.07 to 0.35) | 0.22 (–0.07 to 0.35) | .3050 |
Hydrocephalus | 0.64 (0.44–0.77) | 0.64 (0.45–0.77) | 0.64 (0.45–0.77) | 0.69 (0.54–0.83) | .0259 |
Spinal nodules | 0.58 (0.38–0.74) | 0.58 (0.34–0.73) | 0.61 (0.36–0.77) | 0.46 (0.31–0.65) | .0511 |
Spinal linear disease | 0.44 (0.22–0.63) | 0.52 (0.31–0.65) | 0.45 (0.29–0.6) | 0.66 (0.45–0.84) | .0004 |
Overall response | 0.44 (0.29–0.58) | 0.46 (0.31–0.6) | 0.46 (0.34–0.61) | 0.4 (0.29–0.6) | .2174 |
Non-LM-related items | |||||
Brain parenchymal metastases | 0 (–0.09 to 0.49) | 0 (–0.09 to 0.45) | 0.21 (–0.09 to 0.48) | –0.08 (–0.08 to 0.38) | .1093 |
MRI findings . | All raters (N = 35) . | Neuroradiologists and neurologists (N = 26) . | Neurologists only (N = 17) . | Neuroradiologists only (N = 9) . | P-value between neurologists and neuroradiologists . |
---|---|---|---|---|---|
Number of Kappa analysis | N = 595 | N = 325 | N = 153 | N = 136 | |
LM-related items | |||||
Brain nodules | 0.32 (0.14–0.5) | 0.29 (0.12–0.48) | 0.29 (0.14–0.48) | 0.31 (–0.07 to 0.57) | .3702 |
Brain linear disease | 0.18 (–0.08 to 0.37) | 0.18 (–0.07 to 0.35) | 0.15 (–0.07 to 0.35) | 0.22 (–0.07 to 0.35) | .3050 |
Hydrocephalus | 0.64 (0.44–0.77) | 0.64 (0.45–0.77) | 0.64 (0.45–0.77) | 0.69 (0.54–0.83) | .0259 |
Spinal nodules | 0.58 (0.38–0.74) | 0.58 (0.34–0.73) | 0.61 (0.36–0.77) | 0.46 (0.31–0.65) | .0511 |
Spinal linear disease | 0.44 (0.22–0.63) | 0.52 (0.31–0.65) | 0.45 (0.29–0.6) | 0.66 (0.45–0.84) | .0004 |
Overall response | 0.44 (0.29–0.58) | 0.46 (0.31–0.6) | 0.46 (0.34–0.61) | 0.4 (0.29–0.6) | .2174 |
Non-LM-related items | |||||
Brain parenchymal metastases | 0 (–0.09 to 0.49) | 0 (–0.09 to 0.45) | 0.21 (–0.09 to 0.48) | –0.08 (–0.08 to 0.38) | .1093 |
LM, leptomeningeal metastasis; N, number
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.